CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Shareholder vote results
- 8-K Event Material agreement · Other events
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-3/A Offering Registration Statement
- 8-K/A Event Exhibits
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Results of operations · Delisting notice
- 10-Q Report Quarterly Report
- S-3 Offering Registration Statement
- 8-K/A Event Exhibits
- 10-K/A Report 10-K/A
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 50 of 64 · 1,276 filings